Tetraxim Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Diphtheria toxoid ≥20 IU, tetanus toxoid ≥40 IU, Pertussis toxoid 25 mcg, filamentous haemagglutinin 25 mcg, inactivated poliomyelitis virus type 1 (Mahoney) 29 D-antigen u, inactivated poliomyelitis virus type 2 (MEF-1) 7 D-antigen u, inactivated poliomyelitis virus type 3 (Saukett) 26 D-antigen units

Indications/Uses

Joint prevention of diphtheria, tetanus, pertussis & poliomyelitis for primary vaccination in infants from 2 mth; for booster vaccination.

Dosage/Direction for Use

IM Primary vaccination Can be given as 3 doses at 1-2 mth intervals starting at the age of 2 or 3 mth. Booster vaccination 1 inj in the 2nd yr of life (ie, usually between 16 & 18 mth).

Contraindications

Hypersensitivity to active substances & excipients of Tetraxim; glutaraldehyde, neomycin, streptomycin, or polymyxin B; pertussis vaccine (acellular or whole cell). Severe reaction after an inj of the same vaccine or a vaccine containing the same substances. Progressive encephalopathies; encephalopathy w/in 7 days of a previous dose of any vaccine containing pertussis antigens (whole cell or acellular). Postpone vaccination in case of fever or an acute disease.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07CA02 - diphtheria-pertussis-poliomyelitis-tetanus ; Belongs to the class of combined bacterial and viral vaccines.

Regulatory Classification

POM

Presentation/Packing

Form

Tetraxim vaccine

Packing/Price

1's

Tetraxim

Manufacturer:

sanofi pasteur